Variant report
Variant | nsv1012147 |
---|---|
Chromosome Location | chr2:76936019-76957491 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116476678 | chr2:76936025-76936026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114688019 | chr2:76936029-76936030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186397430 | chr2:76936031-76936032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189666739 | chr2:76936035-76936036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561241389 | chr2:76936041-76936042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528248279 | chr2:76936053-76936054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149284483 | chr2:76936055-76936056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540296009 | chr2:76936067-76936068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182346962 | chr2:76936076-76936077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573657338 | chr2:76936102-76936103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185271842 | chr2:76936114-76936115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562946635 | chr2:76936127-76936128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533054304 | chr2:76936138-76936139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545318336 | chr2:76936160-76936161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144485484 | chr2:76936169-76936170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147990912 | chr2:76936172-76936173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377316340 | chr2:76936184-76936185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549050033 | chr2:76936192-76936193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142317861 | chr2:76936206-76936207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146037636 | chr2:76936220-76936221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374930083 | chr2:76936223-76936224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191454785 | chr2:76936226-76936227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367883791 | chr2:76936229-76936230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183295469 | chr2:76936237-76936238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566697238 | chr2:76936250-76936251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188746166 | chr2:76936276-76936277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114787504 | chr2:76936321-76936322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11694778 | chr2:76936386-76936387 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs536248544 | chr2:76936432-76936433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113072172 | chr2:76936452-76936453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567169849 | chr2:76936465-76936466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141757238 | chr2:76936467-76936468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192957678 | chr2:76936468-76936469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560465753 | chr2:76936479-76936480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6718373 | chr2:76936498-76936499 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs542837318 | chr2:76936499-76936500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561115728 | chr2:76936500-76936501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188054625 | chr2:76936507-76936508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534260082 | chr2:76936514-76936515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559086055 | chr2:76936518-76936519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549883468 | chr2:76936567-76936568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150782406 | chr2:76936571-76936572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532155097 | chr2:76936606-76936607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191420493 | chr2:76936619-76936620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139135996 | chr2:76936630-76936631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76869138 | chr2:76936661-76936662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs74966558 | chr2:76936665-76936666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35520776 | chr2:76936680-76936681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201583263 | chr2:76936681-76936682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374458887 | chr2:76936682-76936683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76935200-76949800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:76936000-76938600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr2:76937000-76937200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr2:76938400-76939000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr2:76938400-76939400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr2:76938600-76939000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr2:76938600-76939200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr2:76939000-76947800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr2:76944000-76944200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr2:76955600-76956000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
11 | chr2:76955600-76956200 | Active TSS | HUES48 Cell Line | embryonic stem cell |
12 | chr2:76955800-76956200 | Active TSS | H9 Cell Line | embryonic stem cell |
13 | chr2:76955800-76956200 | Active TSS | HUES64 Cell Line | embryonic stem cell |
14 | chr2:76956000-76957800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr2:76956200-76957400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
16 | chr2:76956200-76957800 | Weak transcription | H9 Cell Line | embryonic stem cell |
17 | chr2:76957400-76957600 | Enhancers | HUES48 Cell Line | embryonic stem cell |